Filter
1088
Text search:
antigen
Featured
Recommendations
150
New Publications
273
Language
Document type
No document type
552
Guidelines
233
Studies & Reports
132
Manuals
55
Fact sheets
47
Strategic & Response Plan
33
Training Material
12
Situation Updates
5
Infographics
5
Brochures
4
Resource Platforms
4
Online Courses
4
Videos
2
Countries / Regions
India
69
Global
44
Germany
38
South Africa
26
Western and Central Europe
24
Africa
24
Nigeria
22
Kenya
22
Uganda
18
Philippines
16
Tanzania
16
Sierra Leone
15
Zambia
15
East and Southern Africa
15
Nepal
13
Ukraine
13
West and Central Africa
13
Latin America and the Carribbean
13
Rwanda
12
Indonesia
12
Liberia
11
Ghana
11
Malawi
11
Russia
11
Ethiopia
10
Zimbabwe
9
Cameroon
8
Namibia
8
Brazil
7
Myanmar / Burma
7
Middle East and North Africa
7
Congo, Democratic Republic of
6
Syria
6
Bangladesh
6
South–East Asia Region
6
Eastern Europe and Central Asia
6
Mozambique
5
USA
4
Cambodia
4
Colombia
4
Lesotho
4
Eastern Europe
4
Saudi Arabia
3
Pakistan
3
Asia
3
Albania
3
Burkina Faso
2
Somalia
2
Iraq
2
Jordan
2
Lebanon
2
Papua New Guinea
2
Sudan
2
Eswatini/ Swaziland
2
Libya
2
Madagascar
2
Iran
2
North America
2
Guinea
1
Senegal
1
Mali
1
Morocco
1
Haiti
1
South Sudan
1
Afghanistan
1
Egypt
1
China
1
Benin
1
Central African Republic
1
Peru
1
North Macedonia
1
Ecuador
1
Botswana
1
Greece
1
Angola
1
Chile
1
Yemen
1
Venezuela
1
Palestine
1
Djibouti
1
Southern Africa
1
Qatar
1
Moldova
1
Kazakhstan
1
Georgia
1
Tunisia
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
409
Clinical Guidelines
156
Pharmacy & Technologies
45
Public Health
35
Women & Child Health
22
Key Resources
19
Capacity Building
8
Toolboxes
COVID-19
206
HIV
128
NTDs
77
TB
71
Rapid Response
70
Ebola
45
Refugee
28
Pharmacy
17
Zika
16
Caregiver
15
Conflict
13
Mental Health
11
AMR
11
Cholera
8
Polio
7
Natural Hazards
6
NCDs
6
Planetary Health
5
Health Financing Toolbox
4
Specific Hazards
3
Global Health Education
3
This annual report gives an overview of WHO lesotho Country office's undertakings and achievements in the context of an extraordinary health emergency. As we walk another mile this year, may we embrace all lessonst leanred in the previous year, learn from what did not work so well and take on new op
...
Cystic echinococcosis (CE) is a well-known neglected parasitic disease. However, evidence supporting the four current treatment modalities is inadequate, and treatment options remain controversial. The aim of this work is to analyse the available data to answer clinical questions regarding medical t
...
The content of these guidelines goes beyond the technicalities of medical needs with additional insights into community empowerment, possible access to welfare and economic opportunities and similar issues. If these are adequately explored, the health and quality of life of people affected and their
...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products
...
The backsliding of immunization coverage during the COVID-19 pandemic, combined with delayed catch-up efforts has resulted in a large and growing immunity gap. There is an urgent need to close this gap, and enable millions of missed children to be vaccinated. The Essential Immunization Recovery Plan
...
This report highlights the work of the World Health Organization (WHO) in Zimbabwe towards contributing to the triple billion targets in the context of the Sustainable Development Goals (SDGs
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o
...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline
...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
Multiple pandemics, numerous outbreaks, thousands of lives lost and billions of dollars of national income wiped out—all since the turn of this century, in barely 17 years—and yet the world’s investments in pandemic preparedness and response remain woefully inadequate. We know by now that the
...
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa
...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors.
...
The key actions, activities, and approaches in this document are organized within each of the 5Cs (see Table 1 in the PDF) and those of the Strategic preparedness and response plan (SPRP) pillars as follows:
National action plan key activities, prioritized for the current context and the current
...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline
...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig
...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for
...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm
...
Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, including advanced age, smoking, and diabetes, are
...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a
...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm
...
